"Exosome" is not one ingredient. It is a category, and within that category, the tissue an exosome is derived from meaningfully changes what it carries and, by extension, what it is suited for. This matters more than most marketing copy suggests. Two exosome preparations can both be accurately labelled "human stem cell-derived exosomes" while having measurably different signalling profiles.
Two common reference tissues
Wharton's jelly is the gelatinous connective tissue within the umbilical cord, collected from healthy, full-term newborn donors. It is the most widely used source for mesenchymal stem cell-derived exosomes in regenerative skincare, and it is the source behind Hakke's Exo-W platform.
Dental pulp is the soft tissue at the centre of a tooth, also a source of mesenchymal stem cells. It is frequently used in research as a comparison tissue, since it is well characterised and yields a distinctly different signalling profile from cord-derived material.
The data: shared markers, different concentrations
When Wharton's jelly and dental pulp–derived exosomes are measured on the same panel of growth factors, the two sources do not track each other. Below are internal laboratory measurements of conditioned media from both sources, expressed in picograms per millilitre (pg/mL):
| Marker | Wharton's Jelly | Dental Pulp |
|---|---|---|
| EGF | 580 | 3,000 |
| HGF | 4,320 | 2,880 |
| IGFBP-2 | 60,150 | 5,800 |
| IGFBP-4 | 650 | 6,000 |
Wharton's jelly–derived material trends notably higher in IGFBP-2 and somewhat higher in HGF. Dental pulp–derived material trends higher in EGF and IGFBP-4. Neither pattern makes one source categorically "better": it reflects differing biological emphasis between the two tissues. These figures are internal laboratory measurements of conditioned media and are not derived from a head-to-head clinical study.
Why the difference exists
Mesenchymal stem cells retain some of the biological character of the tissue they are cultured from. Umbilical cord tissue and dental pulp tissue develop under different conditions and serve different biological roles, and the stem cell populations within them reflect that. When those cells are cultured and their conditioned media collected, the resulting exosome population carries a signalling profile shaped by its tissue of origin, not a generic, interchangeable payload.
Why this matters for formulation
If a manufacturer cannot tell you which tissue an exosome product is derived from, they likely have not characterised it well enough to formulate around it deliberately. Conversely, if a formulation is built with a specific signalling emphasis in mind (elasticity and firmness pathways for a facial serum, or follicle and keratinocyte-related pathways for a scalp product) tissue source is one of the primary levers available to get there.
This is also why comparing two exosome products purely on exosome count, without reference to source or measured composition, tells you very little. Two vials with the same particle count can behave quite differently depending on what is actually inside them.
How Hakke uses this
Hakke's Exo-W platform is derived from Wharton's jelly and used as the basis for Revival Serum. We maintain dental pulp–derived material as an internal reference point specifically to characterise and document these differences, rather than treating "exosome" as a single undifferentiated ingredient. The full bioactive profile, including the growth factor panel above, is available in our clinical documentation. Read more on our exosome science page, or see the broader biology in our guide to what exosomes are.